Step 4: Reporting a Cancer Prevention Clinical Trial
Quarterly and Annual Progress Report Requirements
The purpose of the Quarterly and Annual Reports is to provide a description of the activities during the reporting period, to discuss any problems encountered and to detail the activities planned for the next reporting period.
The Quarterly Progress Report shall be submitted in a format specified by DCP and will include an expenditure summary for the consortium including expenditures specific to each clinical trial.
All Quarterly and Annual Progress Reports are submitted to the NCI Contracting Officer, DCP Project Officer, and Head, DCP Protocol Information Office. The first reporting period consists of the first full three calendar months of performance plus any fraction of the initial month. After that, the reporting period is every quarter. At the end of each contract year, an annual (cumulative) report is submitted in lieu of the quarterly report.
